Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia

NCT01056523 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Ribavirin
DRUG: Cytarabine arabinoside

Sponsor

Jewish General Hospital

Collaborators

[object Object]